How should I evaluate and treat an adult with acute unilateral lower‑motor‑neuron facial palsy (suspected Bell’s palsy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Acute Unilateral Lower Motor Neuron Facial Palsy

Start oral corticosteroids (prednisolone 50 mg daily for 10 days OR prednisone 60 mg daily for 5 days followed by a 5-day taper) within 72 hours of symptom onset for all patients ≥16 years old, and implement immediate eye protection measures for those with incomplete eyelid closure. 1

Initial Clinical Assessment

Confirm true lower motor neuron involvement by testing forehead function:

  • Inability to wrinkle the forehead or raise the eyebrow on the affected side confirms peripheral (LMN) facial nerve involvement and distinguishes Bell's palsy from central stroke, which spares the forehead 1, 2
  • Perform a complete cranial nerve examination; any additional cranial nerve deficit excludes Bell's palsy and mandates urgent imaging for brainstem pathology 1, 2
  • Document the severity using the House-Brackmann grading system (1=normal to 6=complete paralysis) to guide prognosis and follow-up 1, 2

Red flags requiring urgent MRI with contrast (not Bell's palsy):

  • Forehead sparing (suggests stroke) 1, 2
  • Other cranial nerve involvement 1, 2
  • Bilateral facial weakness 1, 2
  • Progressive weakness beyond 3 weeks 1
  • Recurrent paralysis on the same side 1
  • Isolated branch paralysis 1
  • Associated neurological symptoms (limb weakness, sensory changes, diplopia, anomia, language disturbance) 3, 4

Diagnostic Testing: What NOT to Order

Do not obtain routine laboratory tests or imaging for typical Bell's palsy presentations – these delay treatment beyond the critical 72-hour window without improving outcomes 1, 2

  • No routine labs (strong recommendation) 1
  • No routine CT or MRI for classic presentations 1
  • No electrodiagnostic testing for incomplete facial paralysis 1
  • Consider electrodiagnostic testing only for complete paralysis, performed 3-14 days after onset 1

Treatment Protocol (Within 72 Hours of Onset)

Corticosteroid therapy (MANDATORY):

  • Prednisolone 50 mg once daily for 10 days (no taper needed) 1
    • OR Prednisone 60 mg once daily for 5 days, then taper by 10 mg daily for 5 days (stop on day 11) 1
  • Evidence: 83% recovery at 3 months with steroids vs 64% with placebo (NNT=6) 1
  • At 9 months: 94% recovery with steroids vs 82% with placebo 1

Antiviral therapy (OPTIONAL adjunct only):

  • Never prescribe antivirals alone – they are completely ineffective as monotherapy 1, 5
  • May add valacyclovir 1 g three times daily for 7 days OR acyclovir 400 mg five times daily for 10 days in combination with steroids for severe cases 1, 5
  • Modest benefit: 96.5% recovery with combination vs 89.7% with steroids alone (absolute benefit +6.8%) 1
  • This is classified as an "option" rather than a recommendation due to small incremental gain 1

Eye Protection (CRITICAL for All Patients with Incomplete Eye Closure)

Implement immediately to prevent corneal damage:

  • Lubricating ophthalmic drops every 1-2 hours while awake 1
  • Ophthalmic ointment at bedtime for sustained moisture 1
  • Eye taping or patching at night with proper technique instruction to avoid corneal abrasion 1
  • Sunglasses outdoors to protect against wind and debris 1
  • Moisture chambers (polyethylene covers) for severe cases 1

Urgent ophthalmology referral if:

  • Complete inability to close the eye 1
  • Signs of corneal exposure (redness, pain, foreign body sensation, discharge, vision changes) 1
  • Persistent lagophthalmos beyond 3 months 1

Prognosis Based on Initial Severity

Incomplete paralysis (any visible facial movement):

  • Up to 94% complete recovery 1, 2
  • Better prognosis overall 1, 2

Complete paralysis:

  • Approximately 70% complete recovery within 6 months 1
  • Up to 50% risk of incomplete recovery 1, 2
  • 30% may experience permanent facial weakness with contractures 1

Mandatory Follow-Up and Referral Triggers

Refer to facial nerve specialist if:

  • Incomplete facial recovery at 3 months after symptom onset 1
  • New or worsening neurologic findings at any point 1, 3
  • Development of ocular symptoms at any point 1, 3

Typical recovery timeline:

  • Most patients begin showing improvement within 2-3 weeks 1
  • Complete recovery typically occurs within 3-4 months 1

Special Populations

Children:

  • Better prognosis with higher spontaneous recovery rates (up to 90%) 5
  • Corticosteroid benefit is less conclusive in pediatrics 1
  • May consider steroids for severe cases with caregiver shared decision-making 1

Pregnant women:

  • Treat with oral corticosteroids within 72 hours after individualized risk-benefit assessment 1
  • Eye protection measures are safe and essential 1

Diabetic patients:

  • Diabetes is NOT a contraindication to corticosteroids 1
  • Monitor blood glucose every 2-4 hours during first few days of steroid therapy 1
  • Proactively adjust diabetes medications; consider adding NPH insulin with morning steroid dose 1
  • The therapeutic benefit outweighs temporary hyperglycemia risk 1

Common Pitfalls to Avoid

  • Delaying treatment beyond 72 hours eliminates steroid effectiveness 1
  • Prescribing antivirals alone is completely ineffective and delays proper treatment 1
  • Using standard methylprednisolone dose packs provides only 105 mg prednisone-equivalent vs the required 540 mg, representing significant underdosing 1
  • Ordering unnecessary labs or imaging delays treatment and offers no benefit 1
  • Failing to test forehead function can miss central stroke 1, 2
  • Inadequate eye protection can lead to permanent corneal damage 1
  • Missing red flags (other cranial nerve involvement, forehead sparing, progressive weakness) that indicate alternative diagnoses requiring imaging 1, 3, 4

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Bell's Palsy Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Related Questions

What is the appropriate work‑up for a patient with suspected Bell’s palsy?
What is the appropriate acute management plan for an adult male with a 1‑day onset of right‑sided peripheral facial nerve palsy (Bell’s palsy) without other neurologic deficits?
What are the treatment options for Bell's palsy (Idiopathic Facial Paralysis)?
What is the recommended management for Bell's palsy with loss of taste?
What is the immediate treatment for a patient diagnosed with Bell's palsy?
What is the recommended antibiotic regimen for acute sigmoid diverticulitis complicated by an abscess?
What is the appropriate work‑up and management—including acute and preventive therapies and hormonal considerations—for a 45‑55‑year‑old perimenopausal woman presenting with new‑onset or worsening migraines?
What is the recommended evaluation and management for an asymptomatic 53‑year‑old patient with an incidentally discovered cystic lesion in the anterior suprapubic subcutaneous tissue?
What is the appropriate diagnostic work‑up and next step in management for a patient with CT abdomen showing multiple small right iliac fossa (RIF) lymph nodes (6–9 mm), hepatosplenomegaly, and mild bilateral pleural effusion?
What is the recommended management for a Category III dog bite, including wound cleaning, rabies post‑exposure prophylaxis, tetanus update, and antibiotic prophylaxis?
I’m a perimenopausal woman in my mid‑40s‑early‑50s taking oral estradiol 25 µg (estrodot) and progesterone 100 mg daily; a trial of estradiol 50 µg caused marked breast tenderness. I have migraines about every ten days, treated with rimegepant (Nurtec) but the headache often returns the next day. Should I switch to transdermal estradiol gel or a continuous low‑dose combined oral contraceptive for hormone therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.